
Congress trades
Avantor, Inc. (AVTR)
NYSE · Healthcare · 18 congress trades · last filed 12 months ago
About Avantor, Inc.
from the company's filings and listing- Exchange
- NYSE
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Chief executive
- Emmanuel Ligner
- Employees
- 13,500
- Listed since
- May 17, 2019
- Market value
- $10.1B
- Price to earnings
- -
- Earnings per share
- -$0.85
- Dividend yield
- -
Earnings
6 reported quarters · next on Nov 4, 2026| Quarter | EPS | EPS expected | Revenue | Revenue expected | Result |
|---|---|---|---|---|---|
| Q2 FY2026reported Jul 29, 2026 | $0.21 | $0.19 | $1.7B | $1.6B | EPS beatRevenue beat |
| Q1 FY2026reported Apr 29, 2026 | $0.17 | $0.16 | $1.6B | $1.5B | EPS beatRevenue beat |
| Q4 FY2025reported Feb 11, 2026 | $0.22 | $0.21 | $1.7B | $1.6B | EPS beatRevenue beat |
| Q3 FY2025reported Oct 29, 2025 | $0.22 | $0.22 | $1.6B | $1.6B | EPS missRevenue in line |
| Q2 FY2025reported Aug 1, 2025 | $0.24 | $0.25 | $1.7B | $1.6B | EPS missRevenue beat |
| Q1 FY2025reported Apr 25, 2025 | $0.23 | $0.23 | $1.6B | $1.6B | EPS in lineRevenue miss |
Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag marked GAAP compares a GAAP figure the company reported with an adjusted consensus, two different measures, so a one-time gain or charge can move it either way; basis unverified means we could not classify the reported figure. A flag reads n/a only when a number is missing. An estimate is a forecast made by analysts, not a company target.
Executive pay
as filed for 2025 · proxy filed Mar 27, 2026| Executive | Salary | Stock awards | Other | Total |
|---|---|---|---|---|
| R. Brent JonesExecutive Vice President and Chief Financial Officer | $653K | $4.8M | $1.1M | $6.5M |
| Corey WalkerPresident Laboratory Solutions | $700K | $4.2M | $1.1M | $6.0M |
| Emmanuel LignerDirector, President and Chief Executive Officer | $379K | $2.5M | $3.0M | $5.9M |
| Benoit GourdierExecutive Vice President Bioscience Production | $550K | $3.8M | $871K | $5.2M |
| Claudius SokenuExecutive Vice President, Chief Legal and Compliance O | $550K | $2.6M | $624K | $3.7M |
The summary compensation table from the 2025 proxy statement, current executives only. 1 executive who has since left the company is named in that filing and not shown here. Read the filing
Institutional holders
13F positions as of Jun 30, 2026| Holder | Value | Shares | Change | Of company |
|---|---|---|---|---|
| Dodge & Cox | $1.2B | 120,020,974 | +0.3% | 17.75% |
| Blackrock, Inc. | $695.8M | 70,281,231 | +7.0% | 10.39% |
| Vanguard Portfolio Management LLC | $310.3M | 31,343,250 | +0.2% | 4.64% |
| Vanguard Capital Management LLC | $304.9M | 30,802,835 | +0.6% | 4.56% |
| Greenhaven Associates Inc | $243.9M | 24,637,310 | +9.0% | 3.64% |
| State Street Corp | $213.6M | 21,572,974 | +4.1% | 3.19% |
| Dimensional Fund Advisors LP | $202.1M | 20,412,181 | +20.8% | 3.02% |
| Engine Capital Management, LP | $196.6M | 19,860,830 | +0.4% | 2.94% |
| Barrow Hanley Mewhinney & Strauss LLC | $195.4M | 19,735,968 | -11.7% | 2.92% |
| New Mountain Capital, L.L.C. | $138.6M | 14,000,000 | 0.0% | 2.07% |
| Invesco Ltd. | $137.5M | 13,885,360 | +72.0% | 2.05% |
| Geode Capital Management, LLC | $130.5M | 13,180,567 | +2.2% | 1.95% |
A 13F reports long US equity positions 45 days after the quarter ends, so these are positions as they stood on Jun 30, 2026. For a manager's whole book see the fund directory.
Congress trades in AVTR
18 disclosures of 18 on record · median 41d of the 45 allowed| Member | Type | Action | Amount disclosed | Since the trade | Trade date | Disclosed | Delay |
|---|---|---|---|---|---|---|---|
| Gilbert Ray Cisneros, Jr. | Stock | Sale | $1,001 - $15,000 | +13.9%S&P +18.2% · vs S&P 500 -4.4% | Aug 13, 2025 | Sep 12, 2025 | 30d |
| Gilbert Ray Cisneros, Jr. | Stock | Sale | $1,001 - $15,000 | +17.5%S&P +18.6% · vs S&P 500 -1.1% | Aug 12, 2025 | Sep 12, 2025 | 31d |
| Gilbert Ray Cisneros, Jr. | Stock | Sale | $1,001 - $15,000 | +9.4%S&P +20.3% · vs S&P 500 -10.8% | Jul 23, 2025 | Aug 14, 2025 | 22d |
| Lisa C. McClainSpouseFiled late | Stock | Sale | $1,001 - $15,000 | +13.4%S&P +27.8% · vs S&P 500 -14.4% | Jun 17, 2025 | Aug 13, 2025 | 57d |
| Lisa C. McClainSpouseFiled late | Stock | Purchase | $1,001 - $15,000 | +10.3%S&P +27.0% · vs S&P 500 -16.7% | Jun 11, 2025 | Aug 13, 2025 | 63d |
| John James | Stock | Sale | $1,001 - $15,000 | -40.6%S&P +38.4% · vs S&P 500 -79.0% | Sep 4, 2024 | Sep 6, 2024 | 2d |
| John JamesFiled late | Stock | Purchase | $1,001 - $15,000 | -19.8%S&P +73.1% · vs S&P 500 -92.9% | Nov 10, 2023 | Sep 2, 2024 | 297d |
| Daniel S. Goldman | Stock | Sale | $1,001 - $15,000 | -28.5%S&P +71.0% · vs S&P 500 -99.6% | Jul 12, 2023 | Aug 13, 2023 | 32d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | -26.8%S&P +83.0% · vs S&P 500 -109.8% | May 22, 2023 | Jun 12, 2023 | 21d |
| Susie LeeJoint | Stock | Sale | $1,001 - $15,000 | -33.1%S&P +87.5% · vs S&P 500 -120.5% | Nov 30, 2022 | Dec 29, 2022 | 29d |
| Susie LeeJointFiled late | Stock | Sale | $1,001 - $15,000 | +22.5%S&P +207.9% · vs S&P 500 -185.4% | Apr 3, 2020 | Jun 15, 2020 | 73d |
| Susie LeeJoint | Stock | Purchase | $1,001 - $15,000 | -4.1%S&P +156.3% · vs S&P 500 -160.5% | Sep 10, 2019 | Oct 21, 2019 | 41d |
| Susie LeeJointFiled late | Stock | Purchase | $1,001 - $15,000 | -10.6%S&P +165.5% · vs S&P 500 -176.1% | Aug 7, 2019 | Sep 30, 2019 | 54d |
| Susie LeeJoint | Stock | Purchase | $1,001 - $15,000 | -12.3%S&P +156.7% · vs S&P 500 -169.0% | Jul 17, 2019 | Aug 29, 2019 | 43d |
| Susie LeeJoint | Stock | Purchase | $1,001 - $15,000 | -19.1%S&P +154.8% · vs S&P 500 -173.9% | Jul 23, 2019 | Aug 29, 2019 | 37d |
| Susie LeeJoint | Stock | Sale | $1,001 - $15,000 | -19.0%S&P +157.2% · vs S&P 500 -176.2% | Jul 19, 2019 | Aug 29, 2019 | 41d |
| Susie LeeJointFiled late | Stock | Purchase | $1,001 - $15,000 | +2.9%S&P +167.3% · vs S&P 500 -164.4% | May 17, 2019 | Jul 18, 2019 | 62d |
| Susie LeeJoint | Stock | Purchase | $1,001 - $15,000 | -20.2%S&P +161.6% · vs S&P 500 -181.8% | Jun 25, 2019 | Jul 18, 2019 | 23d |
Since the trade: the stock's move from the trade date to the latest close we hold, as of Sep 10, 2026, an estimate, with the S&P 500 over the same window and the difference against it. The figures describe the stock after the trade, not the member's result: the filing carries a band, not a fill, and a sale keeps the same sign, so a positive figure after a sale means the stock kept rising. An option row carries the underlying stock's move. A row marked n/a has no market price. Not investment advice.
Members of Congress reporting a position
1 member · estimate, as of Sep 10, 20261 member reports a position (estimated). The largest estimated position is in the $1,001 - $15,000 band.
| Member | Party, chamber | Estimated position | Share of their portfolio |
|---|---|---|---|
| Daniel S. Goldman | Democrat · House | $1,001 - $15,000 | 0.3% |
Estimate, as of Sep 10, 2026. Each position is modelled from the member's disclosed transactions and annual filings: the midpoint of each disclosed band, moved with the stock's price since the trade. It is a rough estimate of a reported position, not a figure from a filing, which is why it is shown as a band. Share of portfolio sets that estimate against the member's whole estimated public-stock portfolio.
Questions
Which members of Congress have traded AVTR?
Gilbert Ray Cisneros, Jr., Lisa C. McClain, John James, Daniel S. Goldman, Ro Khanna, Susie Lee disclosed AVTR transactions in the filings shown here.
Which members of Congress hold AVTR?
1 member of Congress reports a position in AVTR in the estimate we hold as of Sep 10, 2026. The largest estimated position belongs to Daniel S. Goldman. The estimate is built from disclosed transactions and annual filings, so it is shown as a band rather than a figure from a filing.
How quickly are AVTR trades disclosed?
Congressional disclosures took a median of 41 days, against the 45 the STOCK Act allows.
How to read a STOCK Act filing
WHAT THE FILING ACTUALLY SAYS
Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.
Data as of Sep 10, 2026.
